Health funding

Supply6 is a daily supplements brand that offers products across vitamins, hydration, and fiber. The company aims to simplify foundational nutrition by providing high-quality supplements in convenient formats. With this funding, Supply6 plans to expand its product portfolio and enhance its distribution channels.

Mykare.ai is a healthtech startup focused on leveraging artificial intelligence to enhance healthcare services. The company aims to improve patient outcomes and streamline healthcare processes through its innovative platform. This funding round will support its expansion efforts in the AI healthcare sector.

The Buffalo sleep apnea care startup focuses on providing innovative solutions for individuals suffering from sleep apnea. This funding round aims to support the company's growth and enhance its offerings in the healthcare market.

mykareai is a healthcare startup that utilizes AI tools to enhance patient care and hospital operations. The company aims to streamline processes such as appointments, records, and follow-ups, addressing the growing demand for efficient digital health solutions in India. This recent funding round of $32 million highlights the increasing investor interest in health tech amidst a competitive landscape.

Epitome Therapeutics is a BioTech company focused on advancing precision epigenome editing for programmable gene expression. The company aims to develop new therapeutic approaches based on the precise regulation of gene expression, with a notable emphasis on their CADENCE platform. This funding will help them build their team and advance their development programmes.

The Func. Lab is a nutrition startup that produces health supplements, including protein powders and electrolytes. Launched in 2025, the company emphasizes ingredient transparency and third-party testing to build trust with health-conscious consumers.

Mykare is a healthcare network that aims to enhance healthcare services. The company focuses on improving access and quality of healthcare for its users. This funding round will help expand its operations and services.

Emulsi Biotech is a biotechnology firm based in Lund, Sweden, focused on developing a lipid-based platform for the oral delivery of biological medicines. The company aims to address the challenges of administering biological therapies, which typically require injections due to degradation in the gastrointestinal tract.

Thalia Therapeutics is a UK-based biotechnology company specializing in RNA-based medical solutions. The company has raised €3.1 million to accelerate its clinical-stage oncology and RNA-based pipeline, including the acquisition of Sanmirna Therapeutics, which brings a microRNA therapeutic candidate into its portfolio.

SuperLiving is a wellness and preventive healthcare platform that leverages artificial intelligence to help users improve their nutrition, movement, sleep, and stress management. The platform offers bite-sized learning modules and a 24/7 AI companion, making it distinctive in its approach to personalized health management. The company aims to expand its offerings into diagnostics and personalized care services.

Intu Diagnostics is a Leipzig-based startup that has developed a laboratory-free, electricity-independent cervical cancer screening technology. The company aims to address global health disparities in cervical cancer detection, particularly in regions lacking infrastructure for routine laboratory screening.

PlutoVets is a Stockholm-based veterinary startup that modernizes pet healthcare by integrating physical clinic access with home-based services. The company aims to address the growing demand for flexible and transparent pet healthcare through a hybrid care model that combines dental services, physical consultations, and digital tools.

Hera is a startup focused on transforming non-clinical senior care coordination through an AI-driven platform. It aims to assist families managing the health of aging relatives by replacing fragmented processes with a structured support system. The company has successfully supported over 1,000 families and maintains a high retention rate.

Generate Biomedicines is a biotech startup focused on AI-driven drug discovery, specifically in the generation and optimization of therapeutic proteins. The company aims to significantly reduce the time required for drug discovery, with a pipeline that includes a Phase 3 clinical trial for severe asthma and multiple oncology candidates with FDA Fast Track designation.

Decoy Therapeutics is a biotechnology company focused on developing innovative therapies. The company aims to address unmet medical needs through its unique approach to drug development. This recent financing round will support their ongoing research and development efforts.

Ladder Health is a healthcare technology company focused on improving patient outcomes through innovative solutions. The company aims to streamline healthcare processes and enhance the patient experience. This funding round will help accelerate their growth and development of new technologies.

xCures is a medical records AI startup that uses artificial intelligence to clean and organize messy patient data from various healthcare sources. The company aims to provide doctors and researchers with quick access to a patient's medical history, significantly improving the efficiency of healthcare data management.

Ollin Biosciences is developing treatments for eye diseases, specifically targeting conditions like diabetic macular edema and wet age-related macular degeneration. The company has raised $330 million in Series B funding to support its upcoming Phase 3 trial, making it one of the largest funding rounds for a biotech company in recent years.

TRIMTECH Therapeutics is focused on developing innovative treatments for neurodegenerative diseases. The company aims to address significant unmet medical needs in this area, making it a notable player in the health sector. The recent funding round will support their research and development efforts.

Orange Health Labs is a Bengaluru-based diagnostics and healthcare platform that provides on-demand health testing services, including at-home sample collection for routine diagnostic tests. The company has recently raised $30 million in a Series C funding round, which will help it expand its services and capabilities in the healthcare sector.

Ovum is a startup focused on women's health, providing innovative solutions to address various health issues faced by women. The company has recently tripled its valuation, indicating strong market interest and potential for growth. This funding round will help Ovum expand its offerings and reach more customers.

ChemT Biotechnology is a Singapore-based startup that leverages artificial intelligence to enhance biomanufacturing processes in the pharmaceutical industry. The company aims to address challenges such as long development timelines and high production costs by applying AI to improve the understanding and control of cell behavior during production.

ChemT is a Singapore-based AI biotech startup focused on leveraging artificial intelligence to advance biotechnological solutions. The company aims to innovate in the biotech space, making significant strides in research and development. This funding round will help ChemT accelerate its growth and enhance its product offerings.

Syntax Bio is a biotechnology company focused on developing innovative therapies for genetic diseases. The company aims to address unmet medical needs through its proprietary technology platform. This funding round will help expand its leadership team and board members, enhancing its strategic direction.

Lissun is a tech-enabled mental health platform that provides therapy, counseling, and wellness solutions for individuals and enterprises. The startup has conducted over 35,000 therapy sessions across India and serves over 200 clients through partnerships with corporates, healthcare providers, and educational institutions.

HealthQuad is a healthcare-focused investment firm that aims to support innovative companies in the health sector. The firm has recently raised Rs 550 crore to expand its investment capabilities, targeting a total fund size of Rs 1,700 crore. This funding will enable HealthQuad to invest in promising healthcare startups and technologies.

Three American college students have successfully raised over $1 million for their healthcare startup. This funding will help them develop their innovative solutions aimed at improving healthcare access and efficiency.

Moadna is a Syrian healthtech startup that offers a digital platform for clinic management and online medical appointment booking. It serves clinics, medical centers, and healthcare providers, enabling them to manage appointments, patient records, and medical visits efficiently. The startup aims to support the digital transformation of healthcare operations in Syria.

Flora Fertility provides portable fertility insurance designed to help individuals proactively plan for fertility treatments. The company aims to address the significant financial risks associated with infertility, offering coverage that is not reliant on employer-provided plans.

Kardigan is a cardiovascular drug startup focused on developing innovative treatments for heart conditions. The company has raised significant funding through both private venture capital and an initial public offering, highlighting its rapid growth and the increasing interest in biotech investments. Its lead drug, danicamtiv, is in late-stage testing for dilated cardiomyopathy, a condition currently lacking approved treatments.

Telepatia is developing an AI Doctor aimed at improving healthcare delivery in Latin American hospitals. This innovative solution seeks to enhance patient care and streamline hospital operations through advanced artificial intelligence technology. The recent funding round will support the company's growth and development efforts.

Clair Health is a startup focused on developing a noninvasive wearable device for hormone tracking, aimed at helping women understand their health better. The device utilizes advanced biosensors to monitor hormonal changes and provide insights into various health markers, including cycle irregularities and perimenopause.

Vali Health is a San Francisco-based startup focused on improving the eldercare sector through responsible AI. The company aims to automate workforce management for home care agencies, addressing the logistical challenges they face in coordinating care for seniors.

Everlab is focused on preventive healthcare solutions, aiming to enhance health outcomes through innovative services. The company targets consumers looking for proactive health management options. This funding round will support its growth and expansion in the preventive healthcare market.

The Australian Predictive Healthcare Startup focuses on utilizing advanced analytics and predictive modeling to improve healthcare outcomes. This funding round will help the company expand its technology and reach more healthcare providers. The $46 million raised will be instrumental in scaling their operations and enhancing their product offerings.

Niino is a startup that digitizes non-urgent medical transport through a platform that coordinates specialist providers across Italy. It aims to make booking assisted transport easier, more efficient, and more accessible for individuals with reduced mobility or specific medical needs. The company recently raised €1.26 million in a pre-seed funding round to support its growth in the Italian non-emergency medical transport market.

Kimba is an Israeli startup that has developed an AI-based device designed to improve sleep quality through personalized scent therapy. The company targets individuals suffering from sleep disorders, leveraging olfactory pathways to enhance relaxation and sleep recovery.

Gate2Brain is a Spanish biotech company focused on developing therapeutic candidates for aggressive pediatric and adult brain tumors. The company aims to address high unmet medical needs in central nervous system diseases by enabling therapeutics to cross the blood-brain barrier using its proprietary technology platform.

Zumutor is a biotechnology company focused on advancing cancer therapies. The company aims to enhance the effectiveness of cancer treatments through innovative trial methodologies. This funding round will support their ongoing clinical trials and development efforts.

Zumutor Biologics is a biotech startup focused on developing immuno-oncology therapies that harness the body's innate immune system to fight cancer. The company is advancing its clinical trials for its lead drug candidate ZM008, which is designed to enhance the immune system’s ability to target and destroy cancer cells. This funding round will support ongoing and future clinical trials, including Phase 1 and Phase 2 studies.

Biodimension is a biotechnology firm focused on product development and laboratory infrastructure. The company aims to enhance capabilities in the biotechnology sector, making it a notable player in the industry. This funding round will support their growth and innovation efforts.

Neion Bio is a biotechnology company focused on revolutionizing the production of biologic medicines using advanced genetic engineering techniques. The company targets the pharmaceutical industry, providing innovative solutions for biologics manufacturing through its unique platform that utilizes chicken eggs as production vessels. This funding round will help expand its pipeline and enhance its manufacturing capabilities.

MACC is a company focused on developing care homes. They are acquiring a site in Birmingham to build a 71-bed care home, which highlights their commitment to expanding healthcare facilities in the region.

OurMind is a startup focused on reducing the administrative burden in healthcare through artificial intelligence. By streamlining processes, they aim to improve efficiency for healthcare providers. The recent funding will help them enhance their AI solutions and expand their market reach.

Dentroid is a Canberra-based medtech startup that has developed needle-free dental technology aimed at providing pain relief during dental procedures without traditional local anaesthetic injections. The company has raised $32 million to commercialize its flagship Nuralyte technology through a global partnership with French dental products manufacturer Septodont.

4baseCare is a precision oncology startup that develops genomics-driven cancer diagnostics and AI-powered clinical decision support tools. The company aims to make precision oncology more inclusive for under-represented populations by decentralizing genomic testing infrastructure and expanding its services globally. With a focus on addressing gaps in population-relevant genomic data, 4baseCare is working to enable more personalized cancer treatment.

The microbubble startup is focused on developing innovative gene therapy solutions. With a significant funding round of $125 million, the company aims to launch a clinical trial next year, marking a pivotal step in its growth and development.

Parabilis Medicines is a biotechnology startup focused on developing therapies for 'undruggable' targets, particularly in cancer treatment. The company has raised significant funding to advance its innovative peptide drugs, known as 'Helicons', which aim to target difficult-to-reach cancer-driving proteins. Their most advanced candidate, zolucatetide, is set to enter Phase 3 trials for desmoid tumors in 2027.

Uncovr is a surgical AI startup that aims to transform surgical documentation using artificial intelligence. The company focuses on improving how healthcare providers analyze, document, code, and learn from surgical procedures, addressing significant discrepancies in data utilization within operating rooms.

01Health is a London-based healthcare company that aims to provide specialist care services traditionally found in Harley Street to a broader audience on the high street. This funding round will help them expand their reach and improve accessibility to quality healthcare services.